Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$25 Mln
Revenue (TTM)
$41 Mln
Net Profit (TTM)
$-12 Mln
ROE
-0.9 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
2.4
Industry P/E
--
EV/EBITDA
-0.8
Div. Yield
0 %
Debt to Equity
1.7
Book Value
$0.3
EPS
$-0.4
Face value
--
Shares outstanding
38,511,715
CFO
$-70.17 Mln
EBITDA
$-70.44 Mln
Net Profit
$-85.95 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Myomo (MYO)
| -25.8 | -12.9 | -25.8 | -86.0 | -3.5 | -44.5 | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Myomo (MYO)
| -85.9 | 28.3 | 880.4 | -92.5 | 1.7 | -25.4 | -79.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Myomo (MYO)
|
0.7 | 24.7 | 40.9 | -15.6 | -35.2 | -86.2 | -- | 2.4 |
| 7.8 | 5,176.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 36.1 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 25.9 | 3,989.0 | 2,719.5 | 47.0 | 8.4 | 1.6 | 86.6 | 1.3 | |
| 112.6 | 6,098.9 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 8.9 | |
| 75.7 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.0 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 329.0 | 12,879.6 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.5 | 9.2 | |
| 118.3 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,409.8 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.1 | 2.6 |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled... upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts. Address: 45 Blue Sky Dr., Burlington, MA, United States, 01803 Read more
Chairman, President & CEO
Mr. Paul R. Gudonis
Chairman, President & CEO
Mr. Paul R. Gudonis
Headquarters
Burlington, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Myomo Inc (MYO) is $0.68 (NYSE) as of 01-Apr-2026 16:00 EDT. Myomo Inc (MYO) has given a return of -3.45% in the last 3 years.
Since, TTM earnings of Myomo Inc (MYO) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-2.45
|
3.34
|
|
2024
|
-40.52
|
10.14
|
|
2023
|
-21.63
|
19.61
|
|
2022
|
-0.35
|
0.59
|
|
2021
|
-4.32
|
2.91
|
The 52-week high and low of Myomo Inc (MYO) are Rs 5.04 and Rs 0.61 as of 02-Apr-2026.
Myomo Inc (MYO) has a market capitalisation of $ 25 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Myomo Inc (MYO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.00
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.